Portfolio Tracker
Alle Depots an einem Ort. Dein Gesamtvermögen immer im Blick, tiefgründige Renditeanalysen und Dividendenplaner.
Anzeige
EQS-News

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY 02.10.2026, 23:55 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: CeraVe / Key word(s): Miscellaneous/Research Update
IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY

02.10.2026 / 23:55 CET/CEST
The issuer is solely responsible for the content of this announcement.


New European research finds 81% recognise the importance of protecting skin beyond UV, yet only 22% use products intended to support the skin barrier

VIENNA, Oct. 2, 2026 /PRNewswire/ -- CeraVe, the skincare brand developed with dermatologists and recommended by more than 80,000 dermatologists worldwide, today reveals new research among 6,000 adults across the UK, France, Germany, Italy and Spain, examining how people understand the skin barrier and respond to everyday environmental pressures.

CeraVe takes to the Vienna hills to launch new research.

The findings reveal a gap between awareness and action. While 90% of adults surveyed are concerned about at least one environmental factor affecting their skin and 81% recognise the importance of protection beyond UV exposure, only 22% use products specifically intended to support the skin barrier.

Nearly half (47%) say their skin is more sensitive than it was five years ago, while 50% report dryness linked to their environment or changing weather. Yet just 10% take additional skincare steps when pollution levels are high, and 55% say skincare must be simple or they will not follow the routine.

The research was unveiled during the European Academy of Dermatology and Venereology Congress in Vienna, where CeraVe brought together dermatology, scientific and brand perspectives to explore the need for clearer skin-barrier education and the science behind safe, efficacious skincare.

"People may experience dryness, tightness or sensitivity without realising these can be linked to the skin barrier. While awareness matters, clear and trusted guidance is the most important factor," said Dr Andrew Park, Board-Certified Dermatologist. "That's why I recommend CeraVe to my patients: developed with dermatologists, formulated with three skin-identical ceramides to help restore and maintain the skin barrier, and rigorously evaluated for safety and efficacy."

For CeraVe, safety and efficacy are considered throughout product development, from identifying a genuine skin-health need through formulation and evaluation. Complete formulations are assessed for safety, efficacy, tolerability and suitability, with scientific and medical input and claims validated by Safety, Claims and Regulatory teams.

"The research shows that people are paying closer attention to their skin, but greater awareness also brings a greater need for clarity and trust," said Gene Colon,  Global Senior Vice President of Medical Relations and Communications at CeraVe. "Our responsibility is to make skin health understandable and accessible, while never compromising on safety and efficacy. As the conversation around skin becomes increasingly complex, we want to give people something simple: credible science, effective skincare and the confidence to make informed choices for their skin."

CeraVe hosts fireside chat with dermatology experts and leadership.

CeraVe booth at EADV Congress 2026 in Vienna.

CeraVe logo.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/is-skincare-getting-too-complicated-cerave-makes-the-case-for-safety-efficacy-and-simplicity-302897520.html

rt.gif?NewsItemId=EN62643&Transmission_Id=202610021751PR_NEWS_EURO_ND__EN62643&DateId=20261002


02.10.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2409846  02.10.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer